scout
|Videos|January 3, 2017

A Study Investigating Pembrolizumab in Combination With Eribulin in TNBC

Sara Tolaney, MD, MPH, associate clinical research director of Breast Oncology at the Dana-Farber Cancer Institute in Boston, discusses a clinical trial investigating pembrolizumab in combination with eribulin in triple-negative breast cancer. 

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME